World's Best Scientists 2026 revealed!
Cristina R. Ferrone

Cristina R. Ferrone

D-Index & Metrics

Medicine

D-Index
100
Citations
42377
World Ranking
8209
National Ranking
4254

Overview

Cristina R. Ferrone is affiliated with Harvard University in the United States. Their research primarily focuses on medicine, with extensive work spanning oncology, surgery, epidemiology, cancer research, and pulmonary and respiratory medicine as key subfields.

The scientist's major topics of study include pancreatic and hepatic oncology research, neuroendocrine tumor research advances, cancer genomics and diagnostics, pancreatitis pathology and treatment, cholangiocarcinoma and gallbladder cancer studies, hepatocellular carcinoma treatment and prognosis, and renal cell carcinoma treatment.

Frequent coauthors in their collaborative work include Motaz Qadan, Keith D. Lillemoe, Carlos Fernández-del Castillo, Andrew L. Warshaw, and Theodore S. Hong. These partnerships have contributed significantly to their publication output.

Cristina R. Ferrone has published frequently in several scientific venues, including Annals of Surgery, HPB, Journal of the American College of Surgeons, Gastroenterology, and Journal of Clinical Oncology.

Some of their recent papers are:

  • "Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology" (2021) published in Journal of the National Comprehensive Cancer Network
  • "Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment" (2022) published in Nature Genetics
  • "Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer" (2021) published in Clinical Cancer Research
  • "Neoadjuvant therapy for pancreatic cancer" (2023) published in Nature Reviews Clinical Oncology
  • "Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma" (2020) published in Annals of Surgery

Best Publications

  • Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway

    Jaekyoung Son;Costas A. Lyssiotis;Costas A. Lyssiotis;Haoqiang Ying;Xiaoxu Wang

  • Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

    Leore T. Geller;Michal Barzily-Rokni;Tal Danino;Oliver H. Jonas;Oliver H. Jonas

  • BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma

    Dennie Tompers Frederick;Adriano Piris;Alexandria P. Cogdill;Zachary A. Cooper

  • Pancreatic adenocarcinoma, version 2.2017: Clinical practice guidelines in Oncology

    Margaret A. Tempero;Mokenge P. Malafa;Mahmoud Al-Hawary;Horacio Asbun

  • Pancreatic adenocarcinoma, Version 2.2021

    Margaret A. Tempero;Mokenge P. Malafa;Mahmoud Al-Hawary;Stephen W. Behrman

  • Clinicopathologic correlates of solitary fibrous tumors.

    Jason S. Gold;Cristina R. Antonescu;Cristina Hajdu;Cristina R. Ferrone

  • Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors

    Triantafyllos Stylianopoulos;John D. Martin;John D. Martin;Vikash P. Chauhan;Saloni R. Jain;Saloni R. Jain

  • Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.

    Cristina R. Ferrone;Giovanni Marchegiani;Theodore S. Hong;David P. Ryan

  • Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function

    Andrea Boni;Alexandria P. Cogdill;Ping Dang;Durga Udayakumar

  • High-fat diet enhances stemness and tumorigenicity of intestinal progenitors

    Semir Beyaz;Semir Beyaz;Miyeko D. Mana;Jatin Roper;Jatin Roper;Dmitriy Kedrin;Dmitriy Kedrin

  • Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism.

    Rushika M. Perera;Svetlana Stoykova;Brandon N. Nicolay;Kenneth N. Ross

  • Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment

    Mechteld C. De Jong;Hari Nathan;Georgios C. Sotiropoulos;Andreas Paul

  • Perioperative CA19-9 Levels Can Predict Stage and Survival in Patients With Resectable Pancreatic Adenocarcinoma

    Cristina R. Ferrone;Dianne M. Finkelstein;Sarah P. Thayer;Alona Muzikansky

  • Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells

    David T. Ting;Ben S. Wittner;Matteo Ligorio;Matteo Ligorio;Nicole Vincent Jordan

  • Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial

    Janet E. Murphy;Jennifer Y. Wo;David P. Ryan;Wenqing Jiang

  • Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.

    Peter J. Allen;Deborah Kuk;Carlos Fernandez Del Castillo;Olca Basturk

  • Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

    Theodore S. Hong;Jennifer Y. Wo;Beow Y. Yeap;Edgar Ben-Josef

  • Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?

    Ioannis T Konstantinidis;Andrew Louis Warshaw;Jill Allen;Lawrence Scott Blaszkowsky

  • Pancreatic ductal adenocarcinoma: Long-term survival does not equal cure

    Cristina R. Ferrone;Rafael Pieretti-Vanmarcke;Jordan P. Bloom;Hui Zheng

  • High-fat diet enhances stemness and tumorigenicity of intestinal progenitors

    Assieh Saadatpour;Sue-Jean Hong;Luca Pinello;Yarden Katz

Frequent Co-Authors

Keith D. Lillemoe
Keith D. Lillemoe Harvard University
Andrew L. Warshaw
Andrew L. Warshaw Harvard University
Vikram Deshpande
Vikram Deshpande Harvard University
David P. Ryan
David P. Ryan Harvard University
Andrew X. Zhu
Andrew X. Zhu Harvard University
Jeffrey W. Clark
Jeffrey W. Clark Harvard University
Soldano Ferrone
Soldano Ferrone Harvard University
Mari Mino-Kenudson
Mari Mino-Kenudson Harvard University
Kenneth K. Tanabe
Kenneth K. Tanabe Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in healthcare goes beyond becoming a physician. Many students look for alternative pathways that are flexible, affordable, or have fewer entry barriers. For those interested in patient care, there are easy nursing programs to get into, which provide accessible entry points into nursing without the intense competition found in traditional medical schools.

Others may seek a non-clinical role, such as medical billing and coding. There are medical billing and coding schools with financial aid, helping students gain essential skills while minimizing tuition costs.

Admission tests can be a barrier for some nursing candidates. Fortunately, there are nursing schools that don't require teas or hesi exams, making it easier for a broader group of students to pursue their nursing ambitions.

For those interested in leading healthcare organizations, a healthcare administration degree online accredited program can be an excellent way to advance careers in healthcare management, often at a flexible pace and format.

Best Scientists Citing Cristina R. Ferrone

Trending Scientists